Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.
Verma S, Dal NK, Srivastava A, Bharti R, Siva Reddy DV, Sofi HS, Roy T, Verma K, Raman SK, Azmi L, Ray L, Mugale MN, Singh AK, Singh J, Griffiths G, Misra A.
Verma S, et al. Among authors: azmi l.
AAPS PharmSciTech. 2023 Jun 8;24(5):130. doi: 10.1208/s12249-023-02585-w.
AAPS PharmSciTech. 2023.
PMID: 37291443